Abstract: Provided is an anti-fuse memory including a anti-fuse memory cell including an isolation structure, a select gate, first and second gate insulating layers, an anti-fuse gate, and first, second and third doped regions. The isolation structure is disposed in a substrate. The select gate is disposed on the substrate. The first gate insulating layer is disposed between the select gate and the substrate. The anti-fuse gate is disposed on the substrate and partially overlapped with the isolation structure. The second gate insulating layer is disposed between the anti-fuse gate and the substrate. The first doped region and the second doped region are disposed in the substrate at opposite sides of the select gate, respectively, wherein the first doped region is located between the select gate and the anti-fuse gate. The third doped region is disposed in the substrate and located between the first doped region and the isolation structure.

Abstract: An image inspection device has a platform, a controlling unit, multiple image capture units, and a discharging unit. The platform has a carrier being capable of rotating for carrying products under inspection. The controlling unit is capable of controlling rotation of the carrier. The image capture units are disposed around the platform and electrically connected to the controlling unit. Each image capture unit has a zoom lens electrically connected to the controlling unit for transmitting digital information of images captured by the zoom lens to the controlling unit. The discharging unit is configured to move the products under inspection away from the carrier and electrically connected to the controlling unit.

Abstract: An image inspection device has a platform, a controlling unit, multiple image capture units, and a discharging unit. The platform has a carrier being capable of rotating for carrying products under inspection. The controlling unit is capable of controlling rotation of the carrier. The image capture units are disposed around the platform and electrically connected to the controlling unit. Each image capture unit has a zoom lens electrically connected to the controlling unit for transmitting digital information of images captured by the zoom lens to the controlling unit. The discharging unit is configured to move the products under inspection away from the carrier and electrically connected to the controlling unit.

Abstract: The present invention provides an artificial decapeptide for inducing the development of gonad in crustacean, a medication including the artificial decapeptide and a method of inducing the gonad development of crustacean. The method includes administrating an effective amount of an artificial decapeptide to a crustacean, thereby promoting gonad development of crustaceans, wherein the artificial decapeptide includes a sequence set forth in SEQ ID NO: 2.

Abstract: An artificial decapeptide for inducing vitellogenesis in fish, being an analogue of gonadotropin-releasing hormone of chicken is set forth in SEQ ID NO: 2. The artificial decapeptide can be further developed and manufactured into a preparation, which is capable of inducing vitellogenesis in fish. With the implantation of the preparation into body cavity or body wall of bony fish, the induction of vitellogenesis and ovum maturation in bony fish can be successfully achieved.

Abstract: An artificial decapeptide for inducing vitellogenesis in fish, being an analogue of gonadotropin-releasing hormone of chicken is set forth in SEQ ID NO: 2. The artificial decapeptide can be further developed and manufactured into a preparation, which is capable of inducing vitellogenesis in fish. With the implantation of the preparation into body cavity or body wall of bony fish, the induction of vitellogenesis and ovum maturation in bony fish can be successfully achieved.

Abstract: A time-released medication for applying to crustacean ovarian development comprises a covering oil and a serotonin-related reagent. The covering oil is coated with the serotonin-related reagent and provides a sustainable releasing effect for the serotonin-related reagent. The serotonin-related reagent is selected from a group of serotonin, a precursor of serotonin, a derivative of serotonin and an agonist of serotonin. The coating relationship between the serotonin-related reagent and the covering oil makes them become a time-released medication.

Abstract: An update method for a wireless system of a security system for a vehicle is mainly applied for a vehicle security system to build a two-way connection with a remote host. After the remote host acquires a two-way connection with the security system, new system data is divided into a plurality of packets and sent to the security system sequentially. When the security system has received all of the packets, the complete new system data is taken out to process the system update of the vehicle security system. Therefore, a security system monitored by a remote host is installed in the vehicle. By the remote host processing the system update, the vehicle need not for recall by a vehicle manufacturer, as so to achieve an update objective rapidly and conveniently.

Abstract: A global positioning system (GPS) having instant notification of vehicle status function includes a GPS satellite signal-receiver module (11), a satellite signal-receiving antenna (12), a checking signal processing circuit (20) and a wireless communication module (30). The GPS satellite signal-receiver module (11) acquires an abnormal status of vehicle message from the checking signal processing circuit (20), and via the satellite signal-receiving antenna (12) receives vehicle position data. After processing, the wireless communication module (30) sends the data to a remote host (62) to provide the instant notification of vehicle status. Therefore, the GPS having instant notification of vehicle status function can effectively simplify a module of vehicle theft and security system circuits and components, so as to reduce cost.

Abstract: A combination therapy for treating patients suffering from pre-malignant colon lesions (e.g. polyps) and colon cancer, as well as other malignancies, is disclosed. The patient is treated concurrently with a cycloocygenase-2 inhibitor and at least one compound selected from the group consisting of a microtubule interfering agent, an epithelial growth factor receptor tyrosine protein kinase inhibitor and a vascular endothelial growth factor receptor tyrosine kinase inhibitor.

Abstract: The invention relates to a combination which comprises (a) a cyclooxygenase-2 inhibitor (“COX-2 inhibitor”) and (b) a histone deacetylase inhibitor (“HDAI”) for simultaneous, concurrent, separate or sequential use, especially for use in the treatment of pre-malignant colon lesions or a colon cancer or other malignancies in a mammal, particularly a human. The invention also relates to pharmaceutical compositions comprising such a combination and to a method of treating pre-malignant colon lesions (e.g. polyps) and colon cancer, as well as other malignancies, in a mammal, particularly a human, with such a combination. The present invention further also relates to a commercial package or product comprising such a combination.